Aurobindo gets $23M settlement; Study finds FDA drug shortages data confusing;

> India's Aurobindo Pharma said that it will receive $23.3 million from the former owner of the U.S. neutraceutical company Natrol to settle litigation over financial irregularities found after it bought the business out of bankruptcy. Story

> IPEC-Americas says excipient makers should be achieving a new standard by the third quarter of this year. Report

> Study finds FDA drug shortages data confusing. Report

> Seunghee Kim, a veteran member of South Korea's Ministry of Food and Drug Safety, has been named to become its first female minister. Report

Suggested Articles

The cleaning procedures are so poor at a Zydus Cadila plant in India that the FDA says a sampling found 10 different cross-contaminated products.

Mylan is the most recent drugmaker facing the FDA's ire over a tainted API that led to a global recall of "sartan"-based drugs last year.

Merck MSD's $1.2 billion production restructuring has fallen on a site in France, where more than 200 manufacturing and R&D jobs will be swept away.